GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » Net Income From Continuing Operations

Guobang Pharma (SHSE:605507) Net Income From Continuing Operations : ¥796 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Guobang Pharma Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Guobang Pharma's net income from continuing operations for the three months ended in Mar. 2025 was ¥214 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥796 Mil.

Guobang Pharma Net Income From Continuing Operations Historical Data

The historical data trend for Guobang Pharma's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guobang Pharma Net Income From Continuing Operations Chart

Guobang Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial 810.29 706.23 920.62 609.98 780.58

Guobang Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 198.58 205.79 174.27 201.94 214.26

Guobang Pharma Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥796 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guobang Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » Net Income From Continuing Operations
Comparable Companies
SHSE:603567 SZSE:300026 SHSE:600267 SHSE:600422 SZSE:002020 SZSE:002550 SHSE:600572 SHSE:600812 SHSE:688131 SZSE:002675 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 60, Xingmei Avenue, Provincial High-tech Industrial Park, Zhejiang Province, Xinchang, CHN, 312500
Website
http://www.gbgcn.com
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.

Guobang Pharma Headlines

No Headlines